Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MYPI20043578AMY169670A (en) | 2003-09-03 | 2004-09-02 | Combinations of a pyrimidine containing nnrti with rt inhibitors |
Publication Number | Publication Date |
---|---|
UA92469C2true UA92469C2 (en) | 2010-11-10 |
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200701971AUA92467C2 (en) | 2004-09-02 | 2005-09-02 | Hydrochloride of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl] amino]benzonitrile |
UAA200702178AUA92469C2 (en) | 2004-09-02 | 2005-09-02 | Fumarate of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl amino benzonitrile |
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200701971AUA92467C2 (en) | 2004-09-02 | 2005-09-02 | Hydrochloride of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl] amino]benzonitrile |
Country | Link |
---|---|
CN (2) | CN101068597B (en) |
AP (1) | AP2296A (en) |
CR (1) | CR9031A (en) |
SG (1) | SG155885A1 (en) |
UA (2) | UA92467C2 (en) |
ZA (1) | ZA200701826B (en) |
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013170421A1 (en)* | 2012-05-14 | 2013-11-21 | 上海迪赛诺药业有限公司 | Rilpivirine hydrochloride alcoholate polymorph and preparation method thereof |
CN103420920B (en)* | 2012-05-14 | 2016-04-27 | 上海迪赛诺药业有限公司 | Rilpivrine hydrochloride alcoholate polymorphic form and preparation method thereof |
HRP20240118T1 (en)* | 2016-10-24 | 2024-04-12 | Janssen Sciences Ireland Unlimited Company | Dispersible compositions |
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JO3429B1 (en)* | 2001-08-13 | 2019-10-20 | Janssen Pharmaceutica Nv | Hiv inhibiting pyrimidines derivatives |
MY169670A (en)* | 2003-09-03 | 2019-05-08 | Tibotec Pharm Ltd | Combinations of a pyrimidine containing nnrti with rt inhibitors |
PT1529032E (en)* | 2002-08-09 | 2013-07-11 | Janssen Pharmaceutica Nv | Processes for the preparation of 4- 4- 4-(2 -cyanoethenyl)-2,6-dimethylphenyl )amino) -2-pyrimidinyl)amino benzonitrile |
Publication number | Publication date |
---|---|
CN101068597B (en) | 2012-04-18 |
UA92467C2 (en) | 2010-11-10 |
SG155885A1 (en) | 2009-10-29 |
CR9031A (en) | 2009-01-16 |
AP2296A (en) | 2011-10-31 |
AP2007003934A0 (en) | 2007-04-30 |
CN101068597A (en) | 2007-11-07 |
CN101056673A (en) | 2007-10-17 |
ZA200701826B (en) | 2008-07-30 |
Publication | Publication Date | Title |
---|---|---|
FR16C1025I1 (en) | 4-[[4-[[4-(2-Cyanoethenyl)-2,6-dimethylphenyl]amino]-2-Pyrimidinyl]amino]benzonitrile salt | |
JO2973B1 (en) | Fumarate Salt Of (alphaS, betaR)-6-Bromo-alfa-[2-(dimethylamino)ethyl]-2- Methoxy-alpha-1-naphthalenyl-beta-phenyl-3- Quinolineethanol | |
UA91006C2 (en) | Method for the production of amino crotonyl compounds | |
PL373679A1 (en) | Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile | |
WO2009007441A3 (en) | Crystalline form of (e) 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2 pyrimidinyl]amino]benzonitrile | |
MY122707A (en) | Pharmaceutical compositions | |
ATE541573T1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING LAPATINIB | |
PL1632232T3 (en) | Salt of 4[[4-[[4-(2-Cyanoethenyl)-2,6-dimethylphenyl]amino]-2-Pyrimidinyl]amino]benzonitrile | |
IL181649A0 (en) | Furamate of 4-((4-((4-(2-cyanoethenyl)-2,6-dimethylphenyl)amino)-2-pyrimidinyl)amino) benzonitrile | |
UA92469C2 (en) | Fumarate of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl amino benzonitrile | |
HRP20110563T1 (en) | Salt of 4[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile | |
AP2487A (en) | Fumarate of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]-amino]-2-pyrimidinyl]amino]benzonitrile |